21190985

Source:http://linkedlifedata.com/resource/pubmed/id/21190985

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005910, umls-concept:C0006777, umls-concept:C0014272, umls-concept:C0243192, umls-concept:C0392756, umls-concept:C0442797, umls-concept:C0528200, umls-concept:C2350948
pubmed:issue	3
pubmed:dateCreated	2011-3-7
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00829140
pubmed:abstractText	Lorcaserin, a selective 5-hydroxytryptamine (5-HT)(2C) receptor agonist, reduces body weight. It is unclear whether weight loss is due to reduced energy intake (EI) or also to enhanced energy expenditure (EE).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/K23 DK68052, http://linkedlifedata.com/resource/pubmed/grant/K99-HD060762
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0375362
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/8-chloro-2,3,4,5-tetrahydro-1-methyl..., http://linkedlifedata.com/resource/pubmed/chemical/Benzazepines, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2C, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Receptor Agonists
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1945-7197
pubmed:author	pubmed-author:AndersonChristen MCM, pubmed-author:MartinCorby KCK, pubmed-author:RavussinEricE, pubmed-author:RedmanLeanne MLM, pubmed-author:SanchezMatildeM, pubmed-author:SmithSteven RSR, pubmed-author:ZhangJinkunJ
pubmed:issnType	Electronic
pubmed:volume	96
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	837-45
pubmed:meshHeading	pubmed-meshheading:21190985-Adolescent, pubmed-meshheading:21190985-Adult, pubmed-meshheading:21190985-Aged, pubmed-meshheading:21190985-Appetite, pubmed-meshheading:21190985-Benzazepines, pubmed-meshheading:21190985-Blood Pressure, pubmed-meshheading:21190985-Body Composition, pubmed-meshheading:21190985-Body Mass Index, pubmed-meshheading:21190985-Body Weight, pubmed-meshheading:21190985-Double-Blind Method, pubmed-meshheading:21190985-Energy Intake, pubmed-meshheading:21190985-Energy Metabolism, pubmed-meshheading:21190985-Female, pubmed-meshheading:21190985-Heart Rate, pubmed-meshheading:21190985-Humans, pubmed-meshheading:21190985-Lipids, pubmed-meshheading:21190985-Male, pubmed-meshheading:21190985-Middle Aged, pubmed-meshheading:21190985-Motor Activity, pubmed-meshheading:21190985-Obesity, pubmed-meshheading:21190985-Overweight, pubmed-meshheading:21190985-Oxidation-Reduction, pubmed-meshheading:21190985-Questionnaires, pubmed-meshheading:21190985-Receptor, Serotonin, 5-HT2C, pubmed-meshheading:21190985-Serotonin Receptor Agonists, pubmed-meshheading:21190985-Young Adult
pubmed:year	2011
pubmed:articleTitle	Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure.
pubmed:affiliation	Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, Louisiana 70808, USA.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural